Uterine rupture and dehiscence associated with intravaginal misoprostol cervical ripening |
| |
Authors: | Hill D A Chez R A Quinlan J Fuentes A LaCombe J |
| |
Institution: | Department of Obstetrics and Gynecology, Florida Hospital Family Practice Residency, Orlando, USA. dahmd@mpinet.net |
| |
Abstract: | OBJECTIVE: To evaluate if the prostaglandin E1 analogue misoprostol, when used as an agent for cervical ripening, is associated with uterine rupture. STUDY DESIGN: We performed a two-year retrospective chart review to determine the incidence of uterine rupture in patients with a previous cesarean delivery undergoing cervical ripening or the induction of labor. RESULTS: Uterine dehiscence occurred in 1 and uterine rupture occurred in 3 of 48 women with a prior cesarean delivery treated with 50 micrograms doses of intravaginal misoprostol for cervical ripening. Uterine rupture was found in 1 of 89 women who had an oxytocin infusion for induction of labor and none of the 24 patients who received intravaginal prostaglandin E2 placed for cervical ripening. CONCLUSION: Intravaginal misoprostol appears to be associated with an increased incidence of uterine rupture when used in patients undergoing a trial of labor after cesarean. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|